Engineers Gate Manager’s CytomX Therapeutics CTMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-10,135
| Closed | -$16.2K | – | 1710 |
|
2022
Q4 | $16.2K | Sell |
10,135
-551
| -5% | -$882 | ﹤0.01% | 1611 |
|
2022
Q3 | $15K | Sell |
10,686
-16,928
| -61% | -$23.8K | ﹤0.01% | 1543 |
|
2022
Q2 | $51K | Buy |
27,614
+90
| +0.3% | +$166 | ﹤0.01% | 1788 |
|
2022
Q1 | $73K | Sell |
27,524
-41,429
| -60% | -$110K | ﹤0.01% | 1738 |
|
2021
Q4 | $299K | Buy |
+68,953
| New | +$299K | 0.01% | 1411 |
|
2021
Q3 | – | Sell |
-55,035
| Closed | -$348K | – | 1698 |
|
2021
Q2 | $348K | Buy |
55,035
+25,535
| +87% | +$161K | 0.02% | 1033 |
|
2021
Q1 | $228K | Buy |
+29,500
| New | +$228K | 0.01% | 1515 |
|
2020
Q4 | – | Sell |
-28,409
| Closed | -$189K | – | 1742 |
|
2020
Q3 | $189K | Sell |
28,409
-17,577
| -38% | -$117K | 0.01% | 1442 |
|
2020
Q2 | $383K | Buy |
45,986
+32,786
| +248% | +$273K | 0.02% | 1088 |
|
2020
Q1 | $101K | Buy |
+13,200
| New | +$101K | 0.01% | 1413 |
|